Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The International Journal of Neuropsychopharmacology
|
January 19, 2023
Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers
Priyanka Singh, Ankit Srivastava, Debleena Guin, et al.
Schizophrenia Research
|
January 13, 2015
Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case-control and familial samples
Ajay Jajodia, Harpreet Kaur, Kalpana Kumari, et al.
Journal of Patient Experience
|
March 28, 2022
Patient Satisfaction Scale for Hospitalized COVID-19 Patients: Development and Psychometric Properties
Laxmi Tej Wunadavalli, Sidhartha Satpathy, Sujata Satapathy, et al.
Psychiatry Research
|
October 28, 2017
Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population
Ajay Jajodia, Harpreet Kaur, Ankit Srivastava, et al.
Indian Journal of Psychiatry
|
April 11, 2022
Understanding needs of stakeholders and outcomes desired from a home-based intervention program for "difficult to treat" schizophrenia and related disorders: A qualitative study
Mamta Sood, Rakesh Kumar Chadda, Nishtha Chawla, et al.
Neuropsychiatric Disease and Treatment
|
October 22, 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And Schizophrenia
Ashish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, et al.
International Journal of Molecular Sciences
|
April 26, 2019
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
Ankit Srivastava, Priyanka Singh, Hitesh Gupta, et al.
Neuropsychiatric Disease and Treatment
|
August 15, 2019
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia
Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, et al.
Genomics
|
December 29, 2023
Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response
Priyanka Singh, Ankit Srivastava, Lini Philip, et al.
Journal of Central Nervous System Disease
|
October 18, 2018
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study
Ashish Kumar Gupta, Komal Rani, Surabhi Swarnkar, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The International Journal of Neuropsychopharmacology
|
January 19, 2023
Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers
Priyanka Singh, Ankit Srivastava, Debleena Guin, et al.
Schizophrenia Research
|
January 13, 2015
Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case-control and familial samples
Ajay Jajodia, Harpreet Kaur, Kalpana Kumari, et al.
Journal of Patient Experience
|
March 28, 2022
Patient Satisfaction Scale for Hospitalized COVID-19 Patients: Development and Psychometric Properties
Laxmi Tej Wunadavalli, Sidhartha Satpathy, Sujata Satapathy, et al.
Psychiatry Research
|
October 28, 2017
Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population
Ajay Jajodia, Harpreet Kaur, Ankit Srivastava, et al.
Indian Journal of Psychiatry
|
April 11, 2022
Understanding needs of stakeholders and outcomes desired from a home-based intervention program for "difficult to treat" schizophrenia and related disorders: A qualitative study
Mamta Sood, Rakesh Kumar Chadda, Nishtha Chawla, et al.
Neuropsychiatric Disease and Treatment
|
October 22, 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And Schizophrenia
Ashish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, et al.
International Journal of Molecular Sciences
|
April 26, 2019
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
Ankit Srivastava, Priyanka Singh, Hitesh Gupta, et al.
Neuropsychiatric Disease and Treatment
|
August 15, 2019
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia
Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, et al.
Genomics
|
December 29, 2023
Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response
Priyanka Singh, Ankit Srivastava, Lini Philip, et al.
Journal of Central Nervous System Disease
|
October 18, 2018
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study
Ashish Kumar Gupta, Komal Rani, Surabhi Swarnkar, et al.
Page
of 6